Metraipolis › archive › dc_5e017d9869a9

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis — Europe PMC PMID:42382389

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42382389
DOI
10.3389/fonc.2026.1853205
License (as archived)
solo-consultazione
Archived
2026-10-19T09:27:48.314Z
SHA-256 of the archived text
6f117cdc93ef8b38e84f9493cd53813ef1c6b8afa3ba88e562514434eecf20d7
Stable URL of this page
https://metraipolis.com/documento/dc_5e017d9869a9

How to cite

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis — Europe PMC PMID:42382389 — Europe PMC (en), https://europepmc.org/article/MED/42382389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e017d9869a9 (Metraipolis archive dc_5e017d9869a9, sha256 6f117cdc93ef8b38e84f9493cd53813ef1c6b8afa3ba88e562514434eecf20d7)
BibTeX
@misc{dc5e017d9869a9,
  title = {Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis — Europe PMC PMID:42382389},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382389},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e017d9869a9; sha256 6f117cdc93ef8b38e84f9493cd53813ef1c6b8afa3ba88e562514434eecf20d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382389. Agents can read the archived copy with the MCP tool read_document.